| __timestamp | Lantheus Holdings, Inc. | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 72429000 | 675200000 |
| Thursday, January 1, 2015 | 78634000 | 771800000 |
| Friday, January 1, 2016 | 75374000 | 1205500000 |
| Sunday, January 1, 2017 | 92157000 | 1146500000 |
| Monday, January 1, 2018 | 93326000 | 1125800000 |
| Tuesday, January 1, 2019 | 103132000 | 1166100000 |
| Wednesday, January 1, 2020 | 110171000 | 1175500000 |
| Friday, January 1, 2021 | 218817000 | 1111400000 |
| Saturday, January 1, 2022 | 233827000 | 1210100000 |
| Sunday, January 1, 2023 | 267194000 | 1274600000 |
Unleashing the power of data
In the ever-evolving landscape of corporate finance, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. This analysis delves into the SG&A trends of Lantheus Holdings, Inc. and Perrigo Company plc from 2014 to 2023. Over this period, Lantheus Holdings saw a remarkable increase in SG&A expenses, growing by approximately 270%, from $72 million in 2014 to $267 million in 2023. This surge reflects strategic investments in operational capabilities and market expansion. Meanwhile, Perrigo Company plc maintained a more stable trajectory, with SG&A expenses fluctuating around the $1.1 billion mark, peaking at $1.27 billion in 2023. This stability underscores Perrigo's consistent approach to cost management amidst market challenges. As these companies navigate the complexities of their respective industries, their SG&A strategies offer valuable insights into balancing growth and efficiency.
Novo Nordisk A/S or Lantheus Holdings, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc.
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Perrigo Company plc
Genmab A/S and Lantheus Holdings, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Lantheus Holdings, Inc. or Taro Pharmaceutical Industries Ltd.
SG&A Efficiency Analysis: Comparing Ionis Pharmaceuticals, Inc. and Perrigo Company plc
Comparing SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs Perrigo Company plc Trends and Insights
Breaking Down SG&A Expenses: Perrigo Company plc vs Xenon Pharmaceuticals Inc.
Perrigo Company plc or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Perrigo Company plc and Vericel Corporation
Cost Management Insights: SG&A Expenses for Perrigo Company plc and Mesoblast Limited
Perrigo Company plc or MiMedx Group, Inc.: Who Manages SG&A Costs Better?